Aricept ODT 5mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To take this medication correctly, follow your doctor's instructions and read all the information provided. Continue taking the medication as directed, even if you're feeling well. Take it at bedtime, with or without food, and drink plenty of non-caffeinated liquids unless your doctor advises you to limit your fluid intake.
Before taking the medication, wash and dry your hands. Place the tablet on your tongue and let it dissolve; do not swallow it whole. Only remove the tablet from the blister pack when you're ready to take it, and take it immediately after opening the pack. Do not store the removed tablet for later use. After the tablet has dissolved, drink a glass of water.
Storing and Disposing of Your Medication
Store the medication at room temperature in a dry place, avoiding the bathroom. Keep all medications in a safe location, out of the reach of children and pets. Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. If you're unsure about the best way to dispose of your medication, consult your pharmacist. You may also have access to drug take-back programs in your area.
Missing a Dose
If you miss a dose, skip it and resume your regular schedule. Do not take two doses at the same time or take extra doses. If you miss seven consecutive days of medication, contact your doctor for guidance on how to proceed.
Lifestyle & Tips
- Take Aricept ODT exactly as prescribed by your doctor, usually once daily at bedtime.
- Place the tablet on your tongue, allow it to dissolve, and then swallow with or without water.
- Do not crush, chew, or split the tablet.
- Do not stop taking this medication suddenly without consulting your doctor, as it may worsen symptoms.
- Report any new or worsening side effects to your doctor, especially severe nausea, vomiting, diarrhea, dizziness, fainting, or signs of stomach bleeding (e.g., black or tarry stools).
Available Forms & Alternatives
Available Strengths:
Generic Alternatives:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you experience any of the following symptoms, contact your doctor or seek medical help right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Severe dizziness or fainting
Slow heartbeat
Abnormal heartbeat
Difficulty urinating
Seizures
Heartburn
Severe stomach pain
Vomiting blood or coffee ground-like material
Black, tarry, or bloody stools
New or worsening trouble breathing
Other Possible Side Effects
Like all medications, this drug can cause side effects. However, many people do not experience any side effects or only have mild ones. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:
Dizziness, fatigue, or weakness
Diarrhea, upset stomach, or vomiting
Trouble sleeping
Muscle cramps
Decreased appetite
Weight loss
Headache
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe or persistent nausea, vomiting, or diarrhea
- Black, tarry, or bloody stools (signs of gastrointestinal bleeding)
- Severe dizziness or fainting (syncope)
- Slow heart rate (bradycardia)
- New or worsening muscle cramps or weakness
- Difficulty urinating
- Seizures
- Worsening of respiratory problems (e.g., asthma, COPD)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist assess potential interactions between this medication and other substances you are taking.
* Any existing health problems, as this medication may interact with certain conditions.
To ensure your safety, it is crucial to verify that it is safe to take this medication with all your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
Overdose Information
Overdose Symptoms:
- Severe nausea
- Vomiting
- Salivation
- Sweating
- Bradycardia (slow heart rate)
- Hypotension (low blood pressure)
- Respiratory depression
- Collapse
- Convulsions
- Increased muscle weakness (may be fatal if respiratory muscles are involved)
What to Do:
In case of overdose, seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Atropine sulfate may be used as an antidote for cholinergic crisis.
Drug Interactions
Major Interactions
- Anticholinergic agents (e.g., atropine, scopolamine, benztropine): May antagonize the effects of donepezil.
- Other cholinesterase inhibitors (e.g., rivastigmine, galantamine): Concomitant use is not recommended due to increased risk of cholinergic side effects.
Moderate Interactions
- Succinylcholine, other neuromuscular blocking agents: Donepezil may exaggerate neuromuscular blockade.
- Beta-blockers (e.g., metoprolol, carvedilol): Increased risk of bradycardia and syncope.
- NSAIDs (e.g., ibuprofen, naproxen): Increased risk of gastrointestinal bleeding, especially in patients with a history of ulcers.
- CYP3A4 inhibitors (e.g., ketoconazole, erythromycin, fluoxetine): May increase donepezil plasma concentrations.
- CYP2D6 inhibitors (e.g., quinidine, paroxetine, fluoxetine): May increase donepezil plasma concentrations.
Minor Interactions
- CYP3A4 inducers (e.g., rifampin, phenytoin, carbamazepine, phenobarbital): May decrease donepezil plasma concentrations.
- CYP2D6 inducers (e.g., rifampin): May decrease donepezil plasma concentrations.
Monitoring
Baseline Monitoring
Rationale: To establish baseline cognitive status and track disease progression/response to treatment.
Timing: Prior to initiation of therapy.
Rationale: Donepezil can cause bradycardia and QT prolongation, especially in patients with pre-existing cardiac conditions.
Timing: Prior to initiation, particularly in patients with cardiac risk factors.
Rationale: To monitor for significant weight loss, which can occur with GI side effects.
Timing: Prior to initiation.
Routine Monitoring
Frequency: Every 6-12 months, or as clinically indicated.
Target: Improvement or stabilization of cognitive scores.
Action Threshold: Significant decline may warrant re-evaluation of treatment.
Frequency: Periodically, especially during dose titration or if symptoms of bradycardia/syncope occur.
Target: Within normal limits for the patient.
Action Threshold: Bradycardia (<50 bpm), symptomatic hypotension, or syncope.
Frequency: Regularly, especially during dose titration.
Target: Minimal to no symptoms.
Action Threshold: Persistent or severe symptoms may require dose reduction or discontinuation.
Frequency: Periodically.
Target: Stable.
Action Threshold: Significant unintentional weight loss.
Symptom Monitoring
- Nausea
- Vomiting
- Diarrhea
- Dizziness
- Bradycardia (slow heart rate)
- Syncope (fainting)
- Muscle cramps
- Insomnia
- Anorexia
- Signs of gastrointestinal bleeding (e.g., black, tarry stools; coffee-ground emesis)
Special Patient Groups
Pregnancy
Donepezil is classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Trimester-Specific Risks:
Lactation
It is not known whether donepezil is excreted in human milk. Due to the potential for serious adverse reactions in breastfed infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use
Safety and effectiveness in pediatric patients have not been established. Donepezil is not indicated for use in children.
Geriatric Use
Donepezil is primarily used in the geriatric population for Alzheimer's disease. No specific dose adjustment is required based solely on age. However, geriatric patients may be more susceptible to cholinergic side effects (e.g., bradycardia, syncope, GI upset) and should be monitored closely.
Clinical Information
Clinical Pearls
- Aricept ODT (Orally Disintegrating Tablet) is beneficial for patients who have difficulty swallowing conventional tablets.
- Administer at bedtime to potentially mitigate gastrointestinal side effects like nausea and vomiting, as the patient will be asleep during the peak plasma concentration.
- Therapeutic effects are gradual and may take several weeks to months to become apparent. Patients and caregivers should be counseled on realistic expectations.
- Donepezil does not cure Alzheimer's disease but may help slow the progression of symptoms.
- Monitor for signs of cholinergic crisis, especially during dose escalation or if other cholinergic agents are co-administered.
- Caution should be exercised in patients with a history of asthma, COPD, or other obstructive pulmonary diseases, as cholinesterase inhibitors can increase bronchial secretions and bronchoconstriction.
Alternative Therapies
- Rivastigmine (Exelon, Exelon Patch) - another acetylcholinesterase inhibitor
- Galantamine (Razadyne) - another acetylcholinesterase inhibitor
- Memantine (Namenda) - an NMDA receptor antagonist (often used in moderate to severe AD, sometimes in combination with donepezil)